To determine the effects of an intact extracellular matrix on collagen synthesis, arterial smooth muscle cells (SMCs) were plated sparsely on a cell-free, SMC-derived matrix and examined the following day. Collagen synthesis during a 5-hour incubation by cells on the matrix was reduced to 67% of the control values obtained from cultures on plastic. Total protein synthesis was unaffected. Treatment of the matrix with heparitinase to remove basic fibroblast growth factor (bFGF) before seeding the SMCs abolished the inhibitory effect of the matrix on collagen synthesis. The inhibitory effect was also eliminated by treating the matrix with a neutralizing polyclonal antibody directed against bFGF. Collagen synthesis by SMC cultures grown in wells coated with purified bFGF was only 61% that of control cultures, whereas total protein synthesis remained unchanged. Slot-blot analysis revealed that the relative message level for orl(III) procollagen was reduced in cultures grown on the preexisting matrix or on plastic precoated with bFGF, whereas the al(I) procollagen message was unaffected. These results demonstrate the ability of the extracellular matrix to modulate the synthesis of collagen by arterial SMCs and indicate that bFGF in the matrix is responsible for these effects. (Arteriosclerosis and Thrombosis 1993; 13:680-686)
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C ells in vivo are in contact with an insoluble matrix composed of collagens, elastin, proteoglycans, noncollagenous glycoproteins, and a variety of adherent nonstructural components including growth factors. This extracellular matrix has the capacity to modulate the behavior and phenotype of cells both in vivo and in vitro. Several types of cultured cells have been shown to respond to the substratum onto which they are plated by altering their adhesion, growth, morphology, and protein synthesis patterns.
Numerous studies have shown that preformed matrices, when used as a substratum for cultured cells, may have significant effects on cell proliferation.
1 " 3 In addition, the substratum on which cells are plated can have specific effects on the synthesis of extracellular matrix components. 4 " 6 Previous studies in our laboratory have demonstrated that preconfluent smooth muscle cells (SMCs) grown on fibronectin synthesize significantly less collagen and fibronectin than control SMCs, whereas noncollagenous protein synthesis was unaltered. 7 In contrast, both collagen and fibronectin syn-thesis by postconfluent cells was unaffected by the substratum. Quantification of collagen synthesis and procollagen mRNA levels in SMCs plated on an SMCderived matrix have not been previously reported. Basic fibroblast growth factor (bFGF) is mitogenic for a variety of cell types and has been shown to be angiogenic both in vitro and in vivo. 89 In vitro, several cell types, including arterial SMCs, 10 -12 have been shown to synthesize bFGF. Biochemical and immunological studies have shown that bFGF is present in vivo in a variety of normal tissues including the aorta. 13 ' 14 Extracellular matrices are believed to be reservoirs of bFGF, which may be mobilized by injury or remodeling of tissue. 15 -17 Recent studies propose a potential role for bFGF in the pathogenesis of atherosclerosis. 1448 The effects of bFGF on collagen production and procollagen mRNA levels in arterial SMCs have not been reported.
The presence of bFGF in the matrix is believed to be responsible for several effects that preformed matrices have on cells. Rogelj and colleagues 19 demonstrated that the extracellular matrix of corneal endothelial cells supports the growth of vascular endothelial cells and also has the capacity to stimulate neurite outgrowth in PC12 cells. These effects were shown to be inhibited by an antibody to bFGF. In contrast, the matrix of PF-HR-9 cells, which do not synthesize bFGF, does not support cell growth, nor does it promote neurite outgrowth. PF-HR-9 cells transfected with bFGF cDNA were shown to make bFGF, and the matrix of these cells was capable of stimulating endothelial cell proliferation and neurite formation. Results from this and other studies 1720 have shown that bFGF is responsible or necessary for the proliferative and neurite-stimulating effects of extracellular matrix. However, the components of the matrix responsible for alterations in the biosynthesis of collagen and proteoglycans by cultures grown on matrices have not been identified.
The present study investigates the effects of a preformed SMC matrix on the rate of collagen synthesis in proliferating arterial SMCs. To explore the potential regulatory mechanisms involved, al(I) and cd(III) procollagen mRNA levels were determined. We also show evidence that bFGF is the component of the matrix responsible for the observed effects.
Methods
Cell Culture
Rabbit aortic SMCs were obtained from explants of the medial layer from the thoracic aorta of a young male rabbit as previously described. 21 ' 22 Cells were grown in Dulbecco's modified Eagle's/Ham's F12 (DME/F12) medium (Irvine Scientific, Irvine, Calif.) that contained 0.12% NaHCOj and 10% fetal bovine serum (FBS). Amino acid supplementation resulted in a final concentration of 0.25 mM L-proline. Cultures were maintained at 37°C in 95% air and 5% CO 2 . Unless otherwise stated, 100-mm Petri dishes were used (Costar, Cambridge, Mass.). SMC cultures from passages 5-9 were used. No differences were observed when different passages were used.
Matrix Preparation
SMCs were plated sparsely and grown for up to 3 weeks past confluency with the medium replaced as necessary. Cells were lysed with phosphate-buffered saline (PBS) containing 0.5% Triton-X-100 for 10 minutes. The exposed matrix was washed twice in PBS and incubated with serum-free medium containing 100 Kunitz units per milliliter deoxyribonuclease I type IV (Sigma Chemical Co., St. Louis, Mo.) for 15 minutes at room temperature. The matrix was again washed twice in PBS, examined by phase-contrast microscopy, and used immediately. SMCs were plated sparsely (2.68x10"/cm 2 ) on matrix-containing or plastic Petri dishes and maintained for 24 hours in DME/F12 medium containing 10% FBS.
In a separate experiment a group of matrices previously treated with DNase was treated with serum-free medium containing 0.2 IU/mL heparitinase (Sigma) for 1 hour at 37°C. Control matrices were incubated with medium alone. After the incubation, matrices were rinsed twice with PBS and SMCs were plated as described above. In another group of matrices, a neutralizing goat polyclonal antibody against bFGF (R & D Systems, Minneapolis, Minn.) was added to DNasetreated matrices 10 minutes before the addition of cells (final concentration, 10 /ig/mL). Control matrices received equivalent amounts of nonimmune goat immunoglobulin G (IgG).
Collagen and Noncollagenous Protein Synthesis
The synthesis of total collagen and noncollagenous protein was determined by the incorporation of L-[2,3-3 H]proline (New England Nuclear, Boston) into trichloroacetic acid-precipitable protein as previously described. 23 Cells were incubated with fresh growth medium containing 50 jug/mL sodium ascorbate and 10 /LiCi/mL [ 3 H]proline during the final 5 hours of the 24-hour incubation. After the labeling, trichloroacetic acid and tannic acid were added to conditioned medium to a final concentration of 5% and 0.25%, respectively. A solution containing 5% trichloroacetic acid and 0.25% tannic acid was added directly to cell layers. Cell layers were placed at -20°C for a minimum of 30 minutes to facilitate their removal by scraping. The trichloroacetic acid-precipitated material was centrifuged at 4°C and washed five times in cold 5% trichloroacetic acid containing 0.25% tannic acid. The final pellet was hydrolyzed in 6N HCl at 120°C for 18 hours. Hydroxyproline and proline were resolved by ionexchange chromatography over AG 50W-X6 resin (BioRad, Richmond, Calif.) as previously described. 24 Collagen and noncollagenous protein syntheses were calculated from the radioactivity in the hydroxyproline and proline fractions as described. 23 The units of collagen and total protein synthesis are expressed as disintegrations per minute and were calculated to be proportional to the quantities of protein synthesized. 23 To determine the relative levels of types I and HI collagen secreted into the medium, triplicate cultures were labeled with [ 3 H]proline for 5 hours as described above. Ammonium sulfate was added to the conditioned medium to a final concentration of 40% saturation, and samples were incubated on ice for 1 hour. The precipitated protein was collected by centrifugation, washed with 70% ethanol, and dried. The samples were resuspended in 0.5N acetic acid/O.OlN HCl containing 100 jig/mL pepsin (Worthington, Freehold, N.J.). Samples were digested overnight at 4°C, and aliquots equal in total 3 H-labeled protein were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) with delayed reduction by /3-mercaptoethanol using the NOVEX system (Novex, San Diego, Calif.). Bands were visualized by fluorography using EN 3 HANCE (New England Nuclear).
Cell Proliferation SMC proliferation was assayed by [
3 H]thymidine incorporation. Cultures were incubated with fresh growth medium containing 0.5 /xCi/mL [me//jy/-3 H]thymidine (ICN, Costa Mesa, Calif.) and 50 /xg/mL sodium ascorbate for 4 hours. After the incubation, cells were rinsed with cold serum-free medium followed by three washes with cold 5% trichloroacetic acid. Cell layers were solubilized in 0.25N NaOH and counted to determine the amount of radioactivity present.
Effect of bFGF
Six-well tissue culture plates (Costar) were coated with 0, 10, or 100 ng/well human recombinant bFGF (Boehringer Mannheim, Indianapolis, Ind.) for 4 hours at room temperature. A solution of PBS containing 1 mg/mL bovine serum albumin and the appropriate amount of bFGF was used for coating. Wells were rinsed with PBS, and then SMCs were plated at a density of 5x10" cells/well in DME/F12 medium containing 10% FBS. Cultures were maintained for 24 hours. To determine collagen synthesis, [10 fiCi/mL and 50 fig/mL, respectively, during the final 5 hours of the incubation. The collagen digestion assay 25 was used to quantify collagen and noncollagenous protein synthesis in these experiments. Additional studies with varying concentrations of soluble bFGF were also performed.
DNA Determination
SMC cultures were trypsinized, and pellets were resuspended in a solution of 50 mM Na 2 HPO 4 , 2 mM EDTA, and 0.02% NaN 3 (pH 7.4). Samples were sonicated for 60 seconds, and DNA concentration was determined fluorimetrically by the method of Labarca and Paigen. 26 
Slot-Blot Analysis
Cells were solubilized in guanidine isothiocyanate containing mercaptoethanol and sarcosyl, and total RNA was purified by isopycnic centrifugation through cesium chloride.
2728 RNA concentration was determined by its absorbance at 260 nm. Purified RNA was denatured in a solution containing 50% formamide/6% formaldehyde/1 x 3 -(N-morpholino)propanesulfonic acid for 15 minutes at 55°C and applied to a Zeta-probe membrane (Bio-Rad) under gentle vacuum. Blots were prehybridized for 5-10 minutes at 65°C in a buffer containing 1 mM EDTA, 7% SDS, and 0.5 M sodium phosphate (pH 7.2). Hybridization was carried out in fresh buffer containing 5xl0 6 cpm of probe at 65°C overnight. The probes used were random primer [ 32 P]deoxycytidine triphosphate-labeled inserts. Blots were washed in sodium phosphate containing 5% SDS for 30 minutes at 65°C, followed by subsequent washes in sodium phosphate containing 1% SDS for 30-60 minutes at 65°C. Blots were then wrapped in plastic wrap and exposed to Kodak XAR-5 x-ray film and an intensifying screen at -70°C.
The cDNA probes HF677 29 and RJ5, 30 specific for al(I) and al(III) procollagen mRNAs, were the generous gift of Dr. Jeanne Myers. A 1,125-bp cDNA probe complementary to chick a-tubulin 31 was used to detect a-tubulin message.
Results
Arterial SMCs were plated sparsely on either a preformed SMC matrix or directly onto plastic Petri dishes and maintained for 24 hours in DME/F12 medium containing 10% FBS. The following day, [ 3 H]thymidine incorporation, total DNA, collagen synthesis, and relative procollagen mRNA levels were determined. Though not statistically significant in the particular experiment shown, cultures of SMCs grown on the preexisting matrix reproducibly contained at least 10% more DNA than control cultures grown on plastic (Table 1) . Cell adhesion studies demonstrated a higher plating efficiency of SMCs onto the matrix (data not shown). [ 3 H]Thymidine incorporation by cultures grown on the matrix substratum was 25% higher than control cultures ( Table 1) .
The level of collagen synthesis per nanogram DNA by cells maintained on the preformed matrix was reduced to 67% of control cells (Figure 1) . Total protein synthesis was unaffected by the substrata (2,021 ±145 and 1,886±55 dpm/ng DNA for cultures on the matrix and control cultures, respectively). Collagen synthesis rela- tive to total protein synthesis was 3.4±0.2% and 5.5±0.3% for the two groups. Thus, the diminished rate of collagen synthesis is a specific effect. A separate group of matrices was treated with heparitinase to release bFGF activity. 16 - 32 Treatment of the preformed matrix with heparitinase eliminated the inhibitory effect of the matrix on collagen synthesis by SMCs (Table 2 ). Addition to the matrix of a neutralizing polyclonal antibody against bFGF also eliminated the inhibitory effect of the matrix (Figure 2 ). Addition of nonimmune IgG did not affect the inhibitory actions of the matrix on SMC collagen synthesis (Figure 2 ).
To test directly the effect of bFGF on SMC collagen synthesis, SMCs were plated onto plastic culture dishes coated with bFGF. Pretreatment of plastic culture dishes with bFGF suppressed collagen synthesis by SMCs (Figure 3 ). Collagen synthesis per nanogram DNA by cultures seeded into wells preincubated with 100 ng bFGF was reduced to 61% of control cultures. A concentration-dependent inhibition of collagen synthesis was also observed when the bFGF was added to the A group of matrices was treated with serum-free medium containing 0.2 IU/mL heparitinase for 1 hour at 37°C. Control matrices were incubated with medium alone. After incubation, matrices were rinsed twice with phosphate-buffered saline, and smooth muscle cells were plated sparsely. Collagen synthesis was quantified as described in "Methods." Results are expressed as mean±SD, n=4. *p<0.001 when compared with cultures on plastic. tp^O.005 when compared with cultures on a heparitinasetreated matrix.
JNot statistically different when compared with cultures on plastic.
cultures in a soluble form (data not shown). Total protein synthesis was unaffected by bFGF (786 ±73 and 778 ±93 for control cultures and cultures plated into wells coated with 100 ng bFGF, respectively). Collagen synthesis relative to total protein synthesis was found to be 4.8±0.3% and 3.0±0.3% for control and bFGFtreated cultures, respectively. The relative amounts of both type I and type III collagen were found to be decreased in the media of bFGF-treated cultures when compared with control cultures (Figure 4) are shown in Figures 5 and 6 . The al(I) procollagen and the tubulin mRNA levels were unaffected by the substrata. In contrast, the relative level of al(III) procollagen mRNA was significantly reduced in cells grown either on the preformed SMC-derived matrix or in wells coated with bFGF.
Discussion
The interaction of cells with the extracellular matrix is accomplished via cell surface receptors specific for the various matrix components. Through these receptors, -bFGF +bFGF Total protein synthesis by SMCs was not affected by the substratum on which the cells were grown. In cultures maintained on the matrix, the amount of collagen synthesized was reduced to 67% of control cultures. Relative collagen synthesis, expressed as a percentage of total protein synthesis, was therefore reduced by 38-40% in cells maintained on a matrix.
Concomitant with the decreased rate of total collagen synthesis, the relative level of al(III) procollagen mRNA was also reduced in cultures grown on the matrix. The al(I) procollagen message level, however, was unaltered by the substratum.
The suppression of collagen synthesis cannot be explained by the increased growth rates of the SMCs plated on matrix. Even though SMCs on the matrix exhibited a odd) oddll)
25% increase in [
3 H]thymidine incorporation, previous studies in our laboratory have shown that collagen synthesis per cell in rapidly proliferating cultures of SMCs is higher than in nondividing cultures, regardless of whether the SMCs in nondividing or slowly proliferating cultures were rendered quiescent by density arrest or mitogen deprivation. 23 Increased SMC proliferation, therefore, cannot contribute to the specific reduction in collagen synthesis by SMCs maintained on the matrix because proliferation is associated with increased, rather than decreased, collagen synthesis.
Several approaches were taken to determine whether the suppression of collagen synthesis by extracellular matrix was due to bFGF. Heparitinase, which has been shown to release bFGF activity from matrices, 16 -32 removed the inhibitory effects of the matrix on collagen synthesis, suggesting the possible involvement of bFGF. Treatment of the matrices with medium alone also removed a small fraction of the inhibitory activity (compare Figure 1 and Table 2 ), presumably due to endogenous proteolytic activity. 33 To confirm the involvement of bFGF, a neutralizing polyclonal antibody against bFGF was shown to abolish the inhibitory activity of the matrix.
To test directly the possible contribution of bFGF, SMCs were plated into wells coated with bFGF. Cultures grown on the bFGF-coated plates synthesized only 61% of the amount of collagen produced by control cultures, whereas total protein synthesis was unchanged. The relative levels of both types I and III collagen were suppressed by bFGF treatment. The relative level of al(III) procollagen mRNA was likewise decreased. The abundance of al(I) message, however, was unaltered. This suggests that factors other than mRNA levels control type I procollagen synthesis and secretion in these cultures. The results obtained by treating the cells with bFGF paralleled those seen when SMCs were plated on an intact, SMC-generated matrix, The mechanism by which bFGF is released from cells is not clear. Unlike other secretory proteins, bFGF lacks a signal sequence and has been postulated to be released from cells during cell injury or death. It is conceivable, therefore, that the bFGF present in the matrix may have been released from the cultures during the lysis procedure. Previous studies, however, have demonstrated that most of the growth-promoting activity present in the matrix after lysis of endothelial cell cultures had been deposited by viable cells and was not the result of growth factor release during lysis. 215 In addition, Mignatti et al 43 demonstrated that single cells can secrete and respond to endogenous bFGF. When the SMCs used in this study were removed with urea rather than by detergent lysis, the released cells excluded trypan blue, indicating that they were intact. The new cells plated on this matrix still exhibited decreased collagen synthesis, thus indicating that the inhibitory factor or factors were not released during cell lysis (data not shown).
In summary, we have demonstrated that an SMCderived extracellular matrix exerts an inhibitory effect on collagen production by SMCs. This inhibitory effect could be abolished by treatment of the matrix either with heparitinase or with a neutralizing antibody to bFGF. The relative level of al(III) procollagen mRNA was significantly reduced in cultures maintained on the matrix. The steady-state level of al(I) procollagen mRNA, however, was not affected by the substratum. The selective effect of matrix on the al(III) procollagen message level demonstrates distinct regulatory pathways for types I and III collagen in arterial SMCs. The effects of the preformed matrix on both collagen production and procollagen mRNA levels could also be elicited with purified bFGF alone, further confirming that it is the active component of the matrix.
